文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

天津市重症监护病房肾脏替代治疗现状调查

[Investigation about the present status of renal replacement therapy in department of intensive care unit in Tianjin].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论天津市33个ICU调查显示5456例(14.06%)接受RRT,以CVVH为主、肝素抗凝为主,血栓是中断RRT的主要医源性因素,需在RRT模式多样化、抗凝及并发症预防方面改进和规范化。

由天津市重症医学临床质量控制中心与天津市第三中心医院ICU向天津市32家公立医院的33个ICU负责人或骨干发放问卷,收集2020年1月至2021年12月RRT数据,回收有效问卷33份(回收率100%)。调查期间ICU共收治38803例患者,其中5456例(14.06%)接受RRT;启动RRT的主要原因多为肾衰竭、脓毒症和容量超负荷。RRT模式以连续性静脉-静脉血液滤过(CVVH)为主,其次为连续性静脉-静脉血液透析滤过(CVVHDF);碳酸盐置换液为首选;肝素为主要抗凝剂,枸橼酸抗凝使用呈增加趋势,无肝素抗凝多用于出血患者。血栓是多数ICU中断RRT的主要医源性因素,也是导管或循环管路相关并发症的原因,增加抗凝剂剂量后仍显示RRT抗凝无效。

要点

  • 调查期间33个ICU共收治38803例,5456例(14.06%)接受RRT。
  • 启动RRT的主要原因多为肾衰竭、脓毒症和容量超负荷。
  • RRT模式以CVVH为主,其次为CVVHDF,碳酸盐置换液为首选,整体模式和抗凝方式单一。
  • 肝素为主要抗凝剂,枸橼酸抗凝使用呈增加趋势,无肝素抗凝多用于出血患者。
  • 血栓是多数ICU中断RRT的主要医源性因素,也是导管或循环管路相关并发症的原因,增加抗凝剂剂量后仍显示RRT抗凝无效。

适用人群与场景

  • 天津市32家公立医院的33个ICU,调查2020年1月至2021年12月收治并接受RRT的患者。

红旗征与不能漏的情况

  • 血栓是多数ICU中断RRT的主要医源性因素,也是导管或循环管路相关并发症的原因。

研究设计与关键结果

  • 研究类型为问卷调查,由天津市重症医学临床质量控制中心与天津市第三中心医院ICU向33个ICU负责人或骨干发放问卷,回收有效问卷33份,回收率100%。
  • 调查期间ICU共收治38803例患者,其中5456例(14.06%)接受RRT。
  • 启动RRT的原因在多数ICU为肾衰竭、脓毒症和容量超负荷。
  • RRT模式以CVVH为主,其次为CVVHDF,碳酸盐置换液为首选。
  • 肝素为主要抗凝剂,枸橼酸抗凝使用呈增加趋势,无肝素抗凝多用于出血患者;整体RRT模式和抗凝方式单一。
  • 血栓是多数ICU中断RRT的主要医源性因素,也是导管或循环管路相关并发症的原因;增加抗凝剂剂量后仍显示RRT抗凝无效。

证据类型、等级与局限

  • 证据类型为多中心问卷调查,回收率100%。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为天津市ICU的RRT已广泛开展并持续扩大,但在RRT模式多样化、抗凝和并发症预防等方面仍需改进和规范化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To understand the current state of renal replacement therapy (RRT) in intensive care unit (ICU) of Tianjin public hospital, and to provide scientific evidence and direction for homogenized management and overall level improvement of RRT in Tianjin.

METHODS: The questionnaires were distributed to the chief or key staff of 33 ICUs from 32 public hospitals in Tianjin by clinical quality control center for critical care medicine of Tianjin and ICU of Tianjin Third Central Hospital. The RRT data of ICUs from January 2020 to December 2021 was collected, including the type and size of ICU, the number of patients undergoing RRT, reasons for initiating RRT, the RRT modes, the anticoagulation and the complications of RRT and so on.

RESULTS: A total of 33 valid questionnaires were obtained, with a recovery rate of 100%. The result showed that there were 38 803 patients admitted to the selected ICUs during investigation, and 5 456 of them (14.06%) received RRT. In most ICUs, the reasons of initiating RRT were renal failure, sepsis and volume overload. The mode of RRT was mainly continuous venovenous hemofiltration (CVVH), which was followed by continuous venovenous hemodiafiltration (CVVHDF). Carbonate replacement fluid was the first choice. Heparin was the dominant anticoagulant, and there was an increasing trend in the use of citrate anticoagulation simultaneously. However, heparin-free anticoagulation used mostly in bleeding patients. Overall, the RRT modes and anticoagulation methods were single. Thrombosis was the main iatrogenic factor interrupting RRT in most ICUs, and also the reasons for complications related to catheter or circulation pipeline. It still showed an ineffective anticoagulation of RRT even after increasing the dosage of anticoagulants.

CONCLUSIONS: RRT is an important organ support method in ICU, which has been widely carried out in ICUs of Tianjin and continues to expand. Despite the positive performance, it still needs to be improved and standarized in some aspects, such as the diversification of RRT modes, anticoagulation, and the complication prevention.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Gao X, Wang W, Xu L, et al. [Investigation about the present status of renal replacement therapy in department of intensive care unit in Tianjin]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567592. doi:10.3760/cma.j.cn121430-20221114-00980

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。